ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,718.57
      0.28%
      US Tech 100
      19,326.80
      0.15%
      Dow Jones
      42,124.65
      0.15%
      Brent Oil
      73.465
      -0.57%
      Bitcoin
      63,393.87
      -0.36%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Vincerx Inc (VINC) Quote

      Vincerx Inc

      Vincerx Inc (VINC)

      NASDAQ
      0.73
      -0.0004
      (-0.05%)
      At close: September 23 4:00PM
      Delayed by 15 minutes
      0.73
      0.00
      ( 0.00% )
      After Hours: 4:00PM
      Delayed by 15 minutes

      Professional-Grade Tools, for Individual Investors.

      Premium

      Key stats and details

      Current Price
      0.73
      Bid
      0.6998
      Ask
      0.749
      Volume
      90,862
      0.71 Day's Range 0.749
      0.5084 52 Week Range 9.3722
      Market Cap
      21.66M
      Previous Close
      0.7304
      Open
      0.7469
      Last Trade
      5694
      @
      0.7203
      Last Trade Time
      16:00:00
      Financial Volume
      $ 66,830
      VWAP
      0.735508
      Average Volume (3m)
      166,807
      Shares Outstanding
      29,671,903
      Dividend Yield
      -
      PE Ratio
      -14.04
      Earnings Per Share (EPS)
      -1.35
      Revenue
      -
      Net Profit
      -40.16M

      About Vincerx Inc

      Vincerx Pharma Inc is a clinical-stage biopharmaceutical company focused on development and oncology expertise to advance new therapies intended to address unmet medical needs for the treatment of cancer. The company's activities are primarily conducted in the United States. It focuses to develop, u... Vincerx Pharma Inc is a clinical-stage biopharmaceutical company focused on development and oncology expertise to advance new therapies intended to address unmet medical needs for the treatment of cancer. The company's activities are primarily conducted in the United States. It focuses to develop, use, manufacture, commercialize, sublicense and distribute a clinical-stage and follow-on small molecule drug program and a preclinical stage bioconjugation/next-generation ADC platform. Show more

      Sector
      Pharmaceutical Preparations
      Industry
      Blank Checks
      Website
      vincerx.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      2021
      Vincerx Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker VINC. The last closing price for Vincerx was $0.73. Over the last year, Vincerx shares have traded in a share price range of $ 0.5084 to $ 9.3722.

      Vincerx currently has 29,671,903 shares outstanding. The market capitalization of Vincerx is $21.67 million. Vincerx has a price to earnings ratio (PE ratio) of -14.04.

      Ask ADVFN Intelligence (AI)

      VINC Latest News

      More News

      Form SC TO-I/A - Tender offer statement by Issuer: [Amend]

      September 10 2024
      Edgar (US Regulatory)

      Form SC TO-I/A - Tender offer statement by Issuer: [Amend]

      August 19 2024
      Edgar (US Regulatory)

      Form 8-K - Current report

      August 16 2024
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      August 14 2024
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      August 14 2024
      Edgar (US Regulatory)

      Form SC TO-I - Tender offer statement by Issuer

      August 13 2024
      Edgar (US Regulatory)

      Form 10-Q - Quarterly report [Sections 13 or 15(d)]

      August 08 2024
      Edgar (US Regulatory)

      Form 8-K - Current report

      August 08 2024
      Edgar (US Regulatory)

      Vincerx Pharma Reports Second Quarter 2024 Financial Results

      Vincerx continues to enroll its Phase 1 studies of antibody-drug conjugate (ADC) VIP943, with data expected by the end of Q4 2024, and small molecule drug-conjugate (SMDC) VIP236, with data...

      August 08 2024
      GlobeNewswire Inc.

      Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

      August 02 2024
      Edgar (US Regulatory)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10.034.285714285710.70.74850.68051185090.70293138CS
      4-0.03-3.947368421050.760.850.67561585070.75382955CS
      12-0.084-10.31941031940.8140.85860.50841668070.69871787CS
      26-4.29-85.45816733075.026.840.50844561941.45795811CS
      52-0.1624-18.19811743610.89249.37220.50845117712.21338974CS
      156-13.92-95.017064846414.6517.48990.50842521812.44080054CS
      260-19.39-96.371769383720.1226.750.50842264543.9486681CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      AAGRAfrican Agriculture Holdings Inc
      $ 0.00
      (0.00%)
      		0
      AADRAdvisorShares Dorsey Wright ADR ETF
      $ 0.00
      (0.00%)
      		0
      AADIAadi Bioscience Inc
      $ 0.00
      (0.00%)
      		0
      AACIArmada Acquisition Corporation I
      $ 0.00
      (0.00%)
      		0
      AACGATA Creativity Global
      $ 0.00
      (0.00%)
      		0
      AAGRAfrican Agriculture Holdings Inc
      $ 0.00
      (0.00%)
      		0
      AADRAdvisorShares Dorsey Wright ADR ETF
      $ 0.00
      (0.00%)
      		0
      AADIAadi Bioscience Inc
      $ 0.00
      (0.00%)
      		0
      AACIArmada Acquisition Corporation I
      $ 0.00
      (0.00%)
      		0
      AACGATA Creativity Global
      $ 0.00
      (0.00%)
      		0
      AAGRAfrican Agriculture Holdings Inc
      $ 0.00
      (0.00%)
      		0
      AADRAdvisorShares Dorsey Wright ADR ETF
      $ 0.00
      (0.00%)
      		0
      AADIAadi Bioscience Inc
      $ 0.00
      (0.00%)
      		0
      AACIArmada Acquisition Corporation I
      $ 0.00
      (0.00%)
      		0
      AACGATA Creativity Global
      $ 0.00
      (0.00%)
      		0

      VINC Discussion

      View Posts
      Laster Laster 5 months ago
      What a cluster this stock has become.
      Unreal actually. $0.60 to $10 back to $0.60 all within 4 months.
      Can’t believe they didn’t try to do the financing when it was trading above $5.
      👍️0
      RAlbert RAlbert 5 months ago
      Tomorrow will be $1.50
      👍️0
      RAlbert RAlbert 5 months ago
      No news on dilution yet. When will we see a rebound? Seeking money being lost is the painful part of life
      👍️0
      RAlbert RAlbert 5 months ago
      Blood bath. I should have waited one more day.
      👍️0
      Monksdream Monksdream 5 months ago
      Somebody knows something you don’t
      👍️0
      RAlbert RAlbert 5 months ago
      I don’t find the price and volume the capital raise is. Am I missing anything here?
      👍️0
      Monksdream Monksdream 5 months ago
      Check for SEC filings
      👍️0
      RAlbert RAlbert 5 months ago
      Is the capital raise 80% discounted to yesterday price? Insane
      👍️0
      Monksdream Monksdream 5 months ago
      Check for a capital raise which means dilution
      👍️0
      RAlbert RAlbert 5 months ago
      Wonder why there is a steep fall in price when the results are not negative.
      👍️0
      RAlbert RAlbert 5 months ago
      Wonder why there is a steep fall in price when the results are not negative.
      👍️0
      Monksdream Monksdream 6 months ago
      VINC 10Q due 4/3
      👍️0
      Monksdream Monksdream 6 months ago
      VINC 10Q due 3/25
      Next day settlement 5/28 per SEC mandate
      👍️0
      Monksdream Monksdream 7 months ago
      VINC new 52.week hi
      👍️0
      Monksdream Monksdream 7 months ago
      VINC new 52 week high
      👍️0
      Monksdream Monksdream 7 months ago
      VINC in the Barchart Top 10
      https://www.barchart.com/stocks/performance/percent-change/advances?orderBy=percentChange&orderDir=desc
      👍️0
      Tom turtles Tom turtles 7 months ago
      Very nice surprise...🆙⬆️
      👍️0
      Monksdream Monksdream 7 months ago
      VINC new 52 week high
      👍️0
      glenn1919 glenn1919 7 months ago
      VINC..................................https://stockcharts.com/h-sc/ui?s=VINC&p=W&b=5&g=0&id=p86431144783
      👍️0
      Awl416 Awl416 7 months ago
      160k wall getting gobbled up
      👍️0
      Awl416 Awl416 7 months ago
      Another leg. Damn
      👍️0
      Awl416 Awl416 7 months ago
      Who’s poking it?
      👍️0
      Monksdream Monksdream 7 months ago
      VINC under $2
      👍️0
      make it happen make it happen 8 months ago
      It's deficient. Failed to meet NASDAQs listing requirements. I'm expecting a reverse split in the future.
      👍️0
      alchemytrader alchemytrader 9 months ago
      moving...
      👍️0
      Monksdream Monksdream 12 months ago
      VINC under $2
      👍️0

      Your Recent History

      NASDAQ
      VINC
      Vincerx
      Delayed Upgrade Clock